Site Members can sign up for company wide alerts
Investigation Overview
July 16, 2012 (Shareholders Foundation) -- An investigation on behalf of investors in Human Genome Sciences (NASDAQ:HGSI) shares was announced concerning whether the offer by GlaxoSmithKline to acquire Human Genome Sciences at $14.25 per NASDAQ:HGSI share and the takeover process are unfair to investors in NASDAQ:HGSI shares. The investigation by a law firm concerns whether certain of...
You must register (for free) or login to view the entire investigation.